Exhibit 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
Artiva Biotherapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type |
Security Class Title |
Fee Rule |
Amount Registered |
Proposed Maximum Offering Price Per Share |
Maximum Aggregate Offering Price(1) |
Fee Rate |
Amount of Registration Fee(2) | |||||||||
Fees to Be Paid | Equity | Common Stock, $0.0001 par value per share | Rule 457(o) | — |
— |
$192,096,000 |
0.00014760 | $28,354 | ||||||||
Total Offering Amounts | $192,096,000 |
$28,354 | ||||||||||||||
Total Fees Previously Paid | $23,628 | |||||||||||||||
Total Fee Offsets | — | |||||||||||||||
Net Fee Due | $4,726 |
(1) | The registrant previously registered securities on the Registration Statement on Form S-1 (File No. 333-280568) having a proposed maximum aggregate offering price of $160,080,000, which was declared effective by the Securities and Exchange Commission on July 18, 2024. In accordance with Rule 462(b) under the Securities Act, an additional amount of securities having a proposed maximum aggregate offering price of $32,016,000 is hereby registered, which includes shares issuable upon the exercise of the underwriters’ option to purchase additional shares. |
(2) | The registration fee is calculated in accordance with Rule 457(o) under the Securities Act of 1933, as amended, based on the proposed maximum aggregate offering price. |